DBITE
DEAD

Serial Number

90792452

Owner

Amgen (Europe) GmbH

Attorney

Timothy J. Gaul

Filing Date

Jun 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

DBITE Trademark

Serial Number: 90792452

DBITE is a trademark filed by Amgen (Europe) GmbH on June 24, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Amgen (Europe) GmbH

Suurstoffi 22
Risch-Rotkreuz 6343 , CH

Entity Type: 16

Trademark Details

Filing Date

June 24, 2021

Registration Date

Not Registered

Goods & Services

Downloadable educational materials on therapeutic polypeptides and use thereof

Medicaments, namely, polypeptides, for use in the treatment of tumorous diseases, cancer, allergies, autoimmunity, inflammation, osteoporosis, graft versus host diseases, transplant rejection, cardiovascular diseases, metabolic diseases, neurological diseases, and minimal residual diseases

Printed educational materials on therapeutic polypeptides and use thereof; printed educational materials in the field of therapeutic polypeptides and use thereof

Promoting interest and awareness among healthcare practitioners and the public regarding therapeutic polypeptides and use thereof; promoting education for healthcare professionals on health and medical issues, namely, therapeutic polypeptides and use thereof

Providing medical and scientific research information regarding therapeutic polypeptides and use thereof; providing a website featuring medical and scientific research information regarding antibody derivatives and use thereof; providing scientific information regarding antibody derivatives and use thereof; providing a website featuring scientific information regarding antibody derivatives and use thereof

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 12, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 12, 2022 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 18, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 18, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 18, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 16, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 8, 2021 NWOS
NEW APPLICATION ENTERED
Jun 28, 2021 NWAP